Editas Medicine, Inc. (EDIT) Q2 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Editas Medicine, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.049 -- 00:00:04.573 Good morning, and welcome to Editas Medicine's second quarter conference call. 00:00:04.573 -- 00:00:07.776 All participants are now in a listen-only mode. 00:00:07.776 -- 00:00:10.718 There will be a question and answer session at the end of this call. 00:00:10.718 -- 00:00:14.842 Please be advised that this call is being recorded at the company's request. 00:00:14.842 -- 00:00:18.765 I would now like to turn the call over to Christy Barnett, Corporate Communications and 00:00:18.765 -- 00:00:22.486 Investor Relations at Editas Medicine. 00:00:22.628 -- 00:00:28.093 Thank you, Maria. Good morning, everyone, and welcome to our second quarter 2023 conference 00:00:28.093 -- 00:00:32.956 call. Earlier this morning, we issued a press release providing our financial results 00:00:32.956 -- 00:00:38.138 and recent corporate updates. A replay of today's call will be available in the investor 00:00:38.138 -- 00:00:42.879 section of our website approximately two hours after its completion. 00:00:42.879 -- 00:00:46.820 After our prepared remarks, we will open the call for Q&A. 00:00:46.820 -- 00:00:51.401 As a reminder, various remarks that we make during this call about the company's future 00:00:51.401 -- 00:00:56.533 expectations, plans, and prospects constitute forward-looking statements 00:00:56.533 -- 00:01:01.116 for the purposes of the safe harbor provisions under the Private Securities Litigation 00:01:01.116 -- 00:01:04.207 Reform Act of 1995. 00:01:04.379 -- 00:01:09.502 Actual results may differ materially from those indicated by these forward-looking statements 00:01:09.502 -- 00:01:14.927 as a result of various important factors, including those discussed in the Risk Factors 00:01:14.927 -- 00:01:19.990 section of our most rec...